News about Medicine

Need help to quit smoking? Known drug might help reduce nicotine cravings

A drug that was originally developed to treat diabetes and severe overweight might also help people with nicotine dependence, concludes new research from the University of Copenhagen.

PartoMa at IMNHC: The injustice of unfit clinical guidelines in women’s and children’s health

On Wednesday, May 10th, the PartoMa team will host a thematic session at IMNHC titled "The Missing Link between Clinical Guidelines and Clinical Realities: Aligning Together." The session will be moderated by Thomas van…

CBMR secures five-year funding extension from Novo Nordisk Foundation

Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation.

The University of Copenhagen invests in the development of medicines from health-promoting gut bacteria

The University of Copenhagen is the first Danish university to invest in a company based on its own research in a unique collaboration with a venture fund. In April 2023, the spinout GutCRINE ApS received initial fundin…

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.

Hormone predicts ability to maintain weight loss

The appetite hormone neurotensin released by the intestine upon eating may predict our ability to maintain weight loss, new study from the University of Copenhagen concludes.

New malaria study is good news for pregnant women

Each year, 13 million pregnant women get malaria, and as drug resistance increases, the disease is hard to control. A new study provides the WHO with new knowledge on prevention and treatment.

Risk of heart problems makes Danes get flu vaccination

More Danes got vaccinated for the seasonal flu if they received a nudging letter from the health authorities, which linked the flu and the risk of subsequent heart problems, study concludes.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Bartender model predicts how drugs affect each person

A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.

Resistant bacteria are a global problem. Now researchers may have found the solution

A new substance has proven useful for treating staphylococcus infections in people with skin lymphoma. This is good news for the patients, but also for the global threat of antibiotics resistance.

The deadline for the submission to European Journal of Pharmaceutical Sciences VSI: Nordic POP has been extended until May 31

Good news for those that are planning to submit to European Journal of Pharmaceutical Sciences VSI: Nordic POP and are running a bit late!. The submission deadline has been moved to May 31, 2023. Hope for a rush of…

Nature’s future pharmacy in peril

For thousands of years, people have relied on the healing properties of plants – in some places they are still the only freely available remedies to this day. Half of the drugs approved worldwide in the last four decade…

Nature’s future pharmacy in peril

For thousands of years, people have relied on the healing properties of plants – in some places they are still the only freely available remedies to this day. Half of the drugs approved worldwide in the last four decade…

Special issue on Sustainable Pharmacy in Eur J Pharm Sci – the call for papers is now open untill June 2023

One of Nordic POP main priorities of focus in the past years was sustainable pharmaceutical research. together with AI and data riven pharmaceutical research, it was a main topic of 2021 Annual Meeting held by Uppsala…

The deadline for the submission to European Journal of Pharmaceutical Sciences VSI: Nordic POP is near!

The submission deadline to European Journal of Pharmaceutical Sciences VSI: Nordic POP is closing March 31, 2023.

Previously unknown cell mechanism could help counter cancer and aging

In a new study, researchers from the University of Copenhagen discovered an unknown mechanism of how cells ‘remember’ their identity when they divide – the cells’ so-called epigenetic memory.

Change in transfer and breeding instruction forms and reviewing the department’s SOPs

Please read the information here.

Power shutdown at the Biocenter

The power shutdown applies to the entire basement in building 2. It will affect ventilation and other installations in animal facility, including lights (electronic board 2.01.AB). If the shutdown gives rise to…

A more efficient technology for oromucosal drug delivery

The project SAFE Patch recently received 1.5 mill DKK from the Innovation Fund Denmark’s InnoExplorer program to explore and develop the new “SAFE Patch” technology and bring it closer to commercialization.

Construction work near the Biocenter - Test piloting performed

The piloting will begin on Monday Janurary 30th, and it is expected to last approx. 10 working days. AEM is still in dialogue with the contractor, and should you experience any irregularities, you are very welcome to…

Construction work near the Biocenter - Test piloting

As mentioned, the construction work involves driving 32 steel piles into the ground during the month of February. A meeting with the contractor and the Maintenance Department was held yesterday due our concern for the…

Construction work near the Biocenter

There is a risk that this type of construction work may be noisy and can sometimes produce low-frequency vibrations. For further details, please see the attached letter from the construction management (in Danish only).…

Niels Behrendt receives the NNF Distinguished Innovator Grant

Niels Behrendt, group leader at the Finsen Laboratory, Rigshospitalet/BRIC receives the NNF Distinguished Innovator grant for a project focused on creating test ADC therapeutics.